As India nears the rollout of ZyCoV-D, the world’s first DNA-based, needle-free Covid vaccine for individuals aged 12 years and above, one Bengaluru trial site gave the low-down on how the much talked about jab works.
Over the last two years, there has been an unprecedented frenzy to develop new vaccines due to the COVID-19 pandemic, but DNA vaccines have rather stood in the shadow of their mRNA cousins.
The ZyCoV-D vaccine heralds a wave of DNA vaccines for various diseases that are undergoing clinical trials around the world.
We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.
On Friday, the Indian government authorized a needle-free Covid-19 vaccine developed by an indigenous pharmaceutical company.
New Delhi: A decision on the approval of Zydus Cadila’s COVID-19 vaccine Zydus Cov-D is expected soon…
Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot
ZyCov-D when approved will help not only adults but also adolescents in the 12 to 18 years age group
The trial of a needle-free covid vaccine is now being tested on volunteers throughout Australia.
PharmaJet touted results today from a study evaluating its needle-free injection technology as a way to administer the poliovirus vaccine.